Dongwha Pharm.Co.Ltd Capital Reinvestment Ratio
Dongwha Pharm.Co.Ltd capital reinvestment ratio. Dongwha Pharm.Co.Ltd (000020) has a Capital Reinvestment Ratio of 0.16x as of June 2026, meaning it reinvests 0% of its operating cash flow (₩18.34 Billion) in capital expenditures (₩2.96 Billion). See Dongwha Pharm.Co.Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Dongwha Pharm.Co.Ltd (2011–2025)
Capital reinvestment ratio of Dongwha Pharm.Co.Ltd from 2011 to 2025. This chart tracks Dongwha Pharm.Co.Ltd's Capital Reinvestment Ratio across 12 annual periods. See 000020 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Dongwha Pharm.Co.Ltd Capital Reinvestment Ratio by Year (2011–2025)
Dongwha Pharm.Co.Ltd capital reinvestment ratio by year from 2011 to 2025. For the full cash flow conversion analysis, see Dongwha Pharm.Co.Ltd cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 3.52x | ₩15.70 Billion | ₩55.30 Billion | ▲ +290.0% |
| 2023 | 0.90x | ₩29.17 Billion | ₩26.35 Billion | ▲ +43.2% |
| 2022 | 0.63x | ₩29.22 Billion | ₩18.43 Billion | ▲ +3.6% |
| 2021 | 0.61x | ₩36.03 Billion | ₩21.94 Billion | ▼ -7.1% |
| 2020 | 0.66x | ₩52.23 Billion | ₩34.25 Billion | ▲ +81.6% |
| 2019 | 0.36x | ₩13.28 Billion | ₩4.80 Billion | ▲ +267.6% |
| 2016 | 0.10x | ₩25.48 Billion | ₩2.50 Billion | ▲ +120.0% |
| 2015 | 0.04x | ₩19.83 Billion | ₩885.50 Million | ▼ -52.7% |
| 2014 | 0.09x | ₩13.51 Billion | ₩1.28 Billion | ▼ -76.1% |
| 2013 | 0.40x | ₩8.21 Billion | ₩3.24 Billion | ▲ +53.9% |
| 2012 | 0.26x | ₩25.23 Billion | ₩6.48 Billion | ▲ +29.9% |
| 2011 | 0.20x | ₩46.24 Billion | ₩9.15 Billion | — |